Modern genome-wide association studies of mental disorders: focus on the mechanisms of inflammation

Modern genome-wide association studies of mental disorders: focus on the mechanisms of inflammation

 

Authors

 

A.O.Kibitov

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation; Federal State Budgetary Educational Institution of Higher Education “First Saint Petersburg State Medical University named after academician I.P. Pavlov” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

D.S. Shumskaya

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

 

https://doi.org/10.26617/1810-3111-2024-4(125)-56-65

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2024; 4 (125):  56-65.

 

Abstract

The objective of the analytical review is to analyze modern data on the genomics of mental disorders of various methodologies and designs with a focus on the results demonstrating the important role of inflammation mechanisms in the formation and implementation of genetic risk for the most common mental disorders. The analysis of the most important modern comparative genomic studies of several nosological forms of mental disorders (schizophrenia, bipolar disorder, and depression) showed that the mechanisms of formation of genetic risks for those nosological forms were largely associated with various aspects of inflammation. At the same time, the level of association and the direction of the effect differed significantly. Most genetic markers associated with C-reactive protein (CRP), which is an important and informative indicator of inflammatory processes, overlap with genetic markers of mental disorders. There are genetic markers associated simultaneously with CRP and mental disorders with mixed directions of effect. A stable and reproducible causal protective effect of genetically determined CRP level on the risk for developing schizophrenia and, conversely, a risk-increasing effect on the risk for developing bipolar disorder was found in several studies. In addition, schizophrenia and depression demonstrate opposite genomic associations with inflammation. Of extreme importance are the published data on a significant association of CRP levels with suicidal behavior in patients with mood disorders and with the first psychotic episode, in whom genetically determined high CRP levels exceed those in individuals with the probability of suicidal behavior. The results of modern genome-wide association studies, the creation and use of polygenic risk scores, and Mendelian randomization provide convincing direct and indirect evidence of a deep link at the genomic level between the mechanisms of formation of genetic risk of mental disorders and inflammation. The use of direct measurement of the main informative peripheral indicators of the inflammatory process, in particular the level of CRP, demonstrates broad possibilities for the analysis of cause-and-effect relationships between inflammation and mental disorders, the formation of which occurs at the genomic level and forms the pathophysiological phenomena of the etiology and pathogenesis of mental disorders. There is a number of methodological limitations in assessing the cause-and-effect relationships using genomic tools associated with the quality of phenotyping in assessing the clinical phenotypes, as well as with the characteristics of clinical biobank collections.

 

Keywords: mental disorders, inflammation, genome-wide association studies, polygenic risk scores, Mendelian randomization analysis, genomics, genetic risk.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Kibitov A.O., Shumskaya D.S. Modern genome-wide association studies of mental disorders: focus on the mechanisms of inflammation. Siberian Herald of Psychiatry and Addiction Psychiatry.2024; 4 (125): 56-65. https://doi.org/10.26617/1810-3111-2024-4(125)-56-65

 

REFERENCES

  1. NeznanovNG, RukavishnikovGV, KasyanovED, FilippovDS, KibitovAO, MazoGE. Biopsychosocial model in psychiatry as an optimal paradigm for modern biomedical research. Review of Psychiatry and Medical Psychology named after V.M. Bekhterev. 2020;2:3-15.doi: 10.31363/2313-7053-2020-2-3-15(in Russian).
  2. Docherty AR, Moscati AA, Fanous AH. Cross-Disorder Psychiatric Genomics. Curr Behav Neurosci Rep. 2016 Sep;3(3):256-263. doi: 10.1007/s40473-016-0084-3. Epub 2016 Jul 2. PMID: 28042526; PMCID: PMC5198908.
  3. Zhao H, Nyholt DR. Gene-based analyses reveal novel genetic overlap and allelic heterogeneity across five major psychiatric disorders. Hum Genet. 2017 Feb;136(2):263-274. doi: 10.1007/s00439-016-1755-6. Epub 2016 Dec 29. PMID: 28035465.
  4. Cross-Disorder Group of the Psychiatric Genomics Consortium; Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013 Sep;45(9):984-94. doi: 10.1038/ng.2711. Epub 2013 Aug 11. PMID: 23933821; PMCID: PMC3800159.
  5. Bourque VR, Poulain C, Proulx C, Moreau CA, Joober R, Forgeot d'Arc B, Huguet G, Jacquemont S. Genetic and phenotypic similarity across major psychiatric disorders: a systematic review and quantitative assessment. Transl Psychiatry. 2024 Mar 30;14(1):171. doi: 10.1038/s41398-024-02866-3. PMID: 38555309; PMCID: PMC10981737.
  6. Choi SW, Mak TS, O'Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020 Sep;15(9):2759-2772. doi: 10.1038/s41596-020-0353-1.
  7. Lewis CM, Vassos E. Polygenic risk scores: fromresearch tools to clinical instruments. Genome Med. 2020 May 18;12(1):44. doi: 10.1186/s13073-020-00742-5.
  8. Martin AR, Daly MJ, Robinson EB, Hyman SE, Neale BM. Predicting polygenic risk of psychiatric disorders. Biol Psychiatry. 2019 Jul 15;86(2):97-109. doi: 10.1016/j.biopsych.2018.12.015. Epub 2018 Dec 28. PMID: 30737014; PMCID: PMC6599546.
  9. Sanderson E, Glymour MM, Holmes MV, Kang H, Morrison J, Munafò MR, Palmer T, Schooling CM, Wallace C, Zhao Q, Smith GD. Mendelian randomization. Nat Rev Methods Primers. 2022 Feb 10;2:6. doi: 10.1038/s43586-021-00092-5. PMID: 37325194; PMCID: PMC7614635.
  10. Ligthart S, Vaez A, Võsa U, Stathopoulou MG, de Vries PS, Prins BP, Van der Most PJ, Tanaka T, Naderi E, Rose LM, et al. Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet. 2018 Nov 1;103(5):691-706. doi: 10.1016/j.ajhg.2018.09.009. PMID: 30388399; PMCID: PMC6218410.
  11. Warren N, O'Gorman C, Horgan I, Weeratunga M, Halstead S, Moussiopoulou J, Campana M, Yakimov V, Wagner E, Siskind D. Inflammatory cerebrospinal fluid markers in schizophrenia spectrum disorders: A systematic review and meta-analysis of 69 studies with 5710 participants. Schizophr Res. 2024 Apr;266:24-31. doi: 10.1016/j.schres.2024.02.001. Epub 2024 Feb 15. PMID: 38364730.
  12. Toenders YJ, Laskaris L, Davey CG, Berk M, Milaneschi Y, Lamers F, Penninx BWJH, Schmaal L. Inflammation and depression in young people: a systematic review and proposed inflammatory pathways. Mol Psychiatry. 2022 Jan;27(1):315-327. doi: 10.1038/s41380-021-01306-8. Epub 2021 Oct 11. PMID: 34635789.
  13. Sayana P, Colpo GD, Simões LR, Giridharan VV, Teixeira AL, Quevedo J, Barichello T. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017 Sep;92:160-182. doi: 10.1016/j.jpsychires.2017.03.018. Epub 2017 Mar 29. PMID: 28458141.
  14. Tylee DS, Sun J, Hess JL, Tahir MA, Sharma E, Malik R, Worrall BB, Levine AJ, Martinson JJ, Nejentsev S, Speed D, et al. Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am J Med Genet B Neuropsychiatr Genet. 2018 Oct;177(7):641-657. doi: 10.1002/ajmg.b.32652. Epub 2018 Oct 16. PMID: 30325587; PMCID: PMC6230304.
  15. Sewell MDE, Jiménez-Sánchez L, Shen X, Edmondson-Stait AJ, Green C, Adams MJ, Rifai OM, McIntosh AM, Lyall DM, Whalley HC, Lawrie SM. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank. Brain Behav Immun. 2021 Oct;97:32-41. doi: 10.1016/j.bbi.2021.06.002. Epub 2021 Jun 6. PMID: 34107350.
  16. Zhang L, Lizano P, Guo B, Xu Y, Rubin LH, Hill SK, Alliey-Rodriguez N, Lee AM, Wu B, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, Bishop JR. Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders. Brain Behav Immun Health. 2022 Apr 8;22:100459. doi: 10.1016/j.bbih.2022.100459. PMID: 35496776; PMCID: PMC9046804.
  17. Deary V, Hagenaars SP, Harris SE, Hill WD, Davies G, Liewald DCM; International Consortium for Blood Pressure GWAS; CHARGE Consortium Aging and Longevity Group; CHARGE Consortium Inflammation Group; McIntosh AM, Gale CR, Deary IJ. Genetic contributions to self-reported tiredness. Mol Psychiatry. 2018 Mar;23(3):609-620. doi: 10.1038/mp.2017.5. Epub 2017 Feb 14. Erratum in: Mol Psychiatry. 2018 Mar;23(3):789-790. doi: 10.1038/mp.2017.70. PMID: 28194004; PMCID: PMC5822465.
  18. Wang F, Liu YL, Jiang CH, Wu HY, Jin J, Sun YW, He ZX, Kang L, Fang X. Association between psychiatric disorders and irritable bowel syndrome: A bidirectional Mendelian randomization study. J Affect Disord. 2025 Jan 1;368:865-871. doi: 10.1016/j.jad.2024.09.030. Epub 2024 Sep 10. PMID: 39260576.
  19. Georgiou AN, Voskarides K, Zanos P, Chatzittofis A. Investigating the shared genetic basis and causal relationships between mucosa-associated lymphoid tissue inflammation and psychiatric disorders. Front Psychiatry. 2024 Apr 29;15:1379922. doi: 10.3389/fpsyt.2024.1379922. PMID: 38742127; PMCID: PMC11089192.
  20. Chen X, Yao T, Cai J, Fu X, Li H, Wu J. Systemic inflammatory regulators and 7 major psychiatric disorders: A two-sample Mendelian randomization study. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jun 8;116:110534. doi: 10.1016/j.pnpbp.2022.110534. Epub 2022 Feb 9. PMID: 35150783.
  21. Werner MCF, Wirgenes KV, Shadrin AA, Lunding SH, Rødevand L, Hjell G, Ormerod MBEG, Haram M, Agartz I, Djurovic S, Melle I, Aukrust P, Ueland T, Andreassen OA, Steen NE. Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Jun 8;116:110511. doi: 10.1016/j.pnpbp.2022.110511. Epub 2022 Jan 19. PMID: 35063598.
  22. So HC, Chau KL, Ao FK, Mo CH, Sham PC. Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits. Psychol Med. 2019 Jun;49(8):1286-1298. doi: 10.1017/S0033291718001812. Epub 2018 Jul 26. PMID: 30045777.
  23. Lestra V, Romeo B, Martelli C, Benyamina A, Hamdani N. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis. Schizophr Res. 2022 Aug;246:175-186. doi: 10.1016/j.schres.2022.06.026. Epub 2022 Jul 1. PMID: 35785580.
  24. Fatemian H, Moslemi H, Hosseini Y, Moshfeghinia R. C-reactive protein (CRP) level in depressed patients with suicidal behavior: A systematic review and meta-analysis. J Affect Disord. 2024 Dec 1;366:423-433. doi: 10.1016/j.jad.2024.08.135. Epub 2024 Aug 24. PMID: 39187188.
  25. Solmi M, Suresh Sharma M, Osimo EF, Fornaro M, Bortolato B, Croatto G, Miola A, Vieta E, Pariante CM, Smith L, Fusar-Poli P, Shin JI, Berk M, Carvalho AF. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability. Brain Behav Immun. 2021 Oct;97:193-203. doi: 10.1016/j.bbi.2021.07.014. Epub 2021 Jul 28. PMID: 34332041.
  26. Said S, Pazoki R, Karhunen V, Võsa U, Ligthart S, Bodinier B, Koskeridis F, Welsh P, Alizadeh BZ, Chasman DI, Sattar N, Chadeau-Hyam M, Evangelou E, Jarvelin MR, Elliott P, Tzoulaki I, Dehghan A. Genetic analysis of over half a million people characterises C-reactive protein loci. Nat Commun. 2022 Apr 22;13(1):2198. doi: 10.1038/s41467-022-29650-5. Erratum in: Nat Commun. 2022 Jul 5;13(1):3865. doi: 10.1038/s41467-022-31706-5. PMID: 35459240; PMCID: PMC9033829.
  27. Si S, Li J, Tewara MA, Xue F. Genetically determined chronic low-grade inflammation and hundreds of health outcomes in the UK biobank and the finngen population: A phenome-wide mendelian randomization study. Front Immunol. 2021 Jul 27;12:720876. doi: 10.3389/fimmu.2021.720876. PMID: 34386016; PMCID: PMC8353321.
  28. Prins BP, Abbasi A, Wong A, Vaez A, Nolte I, Franceschini N, Stuart PE, Guterriez Achury J, Mistry V, Bradfield JP, et al. Investigating the causal relationship of c-reactive protein with 32 complex somatic and psychiatric outcomes: A large-scale cross-consortium mendelian randomization study. PLoS Med. 2016 Jun 21;13(6):e1001976. doi: 10.1371/journal.pmed.1001976. PMID: 27327646; PMCID: PMC4915710.
  29. Hindley G, Drange OK, Lin A, Kutrolli G, Shadrin AA, Parker N, O'Connell KS, Rødevand L, Cheng W, Bahrami S, Karadag N, Holen B, Jaholkowski P, Woldeyohannes MT, Djurovic S, Dale AM, Frei O, Ueland T, Smeland OB, Andreassen OA. Cross-trait genome-wide association analysis of C-reactive protein level and psychiatric disorders. Psychoneuroendocrinology. 2023 Nov;157:106368. doi: 10.1016/j.psyneuen.2023.106368. Erratum in: Psychoneuroendocrinology. 2024 Apr;162:106980. doi: 10.1016/j.psyneuen.2024.106980. PMID: 37659117; PMCID: PMC10802833.
  30. Miola A, Dal Porto V, Tadmor T, Croatto G, Scocco P, Manchia M, Carvalho AF, Maes M, Vieta E, Sambataro F, Solmi M. Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: A systematic review and meta-analysis. Acta Psychiatr Scand. 2021 Dec;144(6):537-552. doi: 10.1111/acps.13351. Epub 2021 Aug 25. PMID: 34292580; PMCID: PMC9290832.
  31. Kuppa A, Tripathi H, Al-Darraji A, Tarhuni WM, Abdel-Latif A. C-Reactive protein levels and risk of cardiovascular diseases: A two-sample bidirectional mendelian randomization study. Int J Mol Sci. 2023 May 23;24(11):9129. doi: 10.3390/ijms24119129. PMID: 37298077; PMCID: PMC10252732.
  32. Lee YH, Thaweethai T, Sheu YH, Feng YA, Karlson EW, Ge T, Kraft P, Smoller JW. Impact of selection bias on polygenic risk score estimates in healthcare settings. Psychol Med. 2023 Nov;53(15):7435-7445. doi: 10.1017/S0033291723001186. Epub 2023 May 25. PMID: 37226828.